These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 9915315
1. Milrinone modulates endotoxemia, systemic inflammation, and subsequent acute phase response after cardiopulmonary bypass (CPB). Möllhoff T, Loick HM, Van Aken H, Schmidt C, Rolf N, Tjan TD, Asfour B, Berendes E. Anesthesiology; 1999 Jan; 90(1):72-80. PubMed ID: 9915315 [Abstract] [Full Text] [Related]
2. Effect of low-dose milrinone on gastric intramucosal pH and systemic inflammation after hypothermic cardiopulmonary bypass. Yamaura K, Okamoto H, Akiyoshi K, Irita K, Taniyama T, Takahashi S. J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):197-203. PubMed ID: 11312479 [Abstract] [Full Text] [Related]
3. Markers of splanchnic perfusion and intestinal translocation of endotoxins during cardiopulmonary bypass: effects of dopamine and milrinone. McNicol L, Andersen LW, Liu G, Doolan L, Baek L. J Cardiothorac Vasc Anesth; 1999 Jun; 13(3):292-8. PubMed ID: 10392680 [Abstract] [Full Text] [Related]
4. Effects of dopexamine on creatinine clearance, systemic inflammation, and splanchnic oxygenation in patients undergoing coronary artery bypass grafting. Berendes E, Möllhoff T, Van Aken H, Schmidt C, Erren M, Deng MC, Weyand M, Loick HM. Anesth Analg; 1997 May; 84(5):950-7. PubMed ID: 9141914 [Abstract] [Full Text] [Related]
5. Increased plasma concentrations of serum amyloid A: an indicator of the acute-phase response after cardiopulmonary bypass. Berendes E, Möllhoff T, Aken HV, Erren M, Deng MC, Loick HM. Crit Care Med; 1997 Sep; 25(9):1527-33. PubMed ID: 9295827 [Abstract] [Full Text] [Related]
7. Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-alpha concentrations in patients undergoing cardiopulmonary bypass. Andersen LW, Landow L, Baek L, Jansen E, Baker S. Crit Care Med; 1993 Feb; 21(2):210-7. PubMed ID: 8428471 [Abstract] [Full Text] [Related]
9. Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: comparison of patients with a low and high prebypass cardiac index. Yamada T, Takeda J, Katori N, Tsuzaki K, Ochiai R. J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):367-73. PubMed ID: 10972598 [Abstract] [Full Text] [Related]
10. Inhibition of phosphodiesterase type III before aortic cross-clamping preserves intramyocardial cyclic adenosine monophosphate during cardiopulmonary bypass. Janelle GM, Urdaneta F, Blas ML, Shryock J, Tang YS, Martin TD, Lobato EB. Anesth Analg; 2001 Jun; 92(6):1377-83. PubMed ID: 11375808 [Abstract] [Full Text] [Related]
11. [Effect of inhaling specific phosphodiesterase inhibitor on lung injury induced by cardiopulmonary bypass]. Guo HW, Wang WJ, Liao CX, Yang Q, Shan ZG, Qiu F, Chen JK. Zhonghua Yi Xue Za Zhi; 2011 May 31; 91(20):1401-4. PubMed ID: 21756812 [Abstract] [Full Text] [Related]
18. Milrinone, not epinephrine, improves left ventricular compliance after cardiopulmonary bypass. Lobato EB, Gravenstein N, Martin TD. J Cardiothorac Vasc Anesth; 2000 Aug 31; 14(4):374-7. PubMed ID: 10972599 [Abstract] [Full Text] [Related]
19. Splanchnic oxygen transport and lactate metabolism during normothermic cardiopulmonary bypass in humans. Haisjackl M, Birnbaum J, Redlin M, Schmutzler M, Waldenberger F, Lochs H, Konertz W, Kox W. Anesth Analg; 1998 Jan 31; 86(1):22-7. PubMed ID: 9428845 [Abstract] [Full Text] [Related]
20. Effects of the phosphodiesterase III inhibitors olprinone, milrinone, and amrinone on hepatosplanchnic oxygen metabolism. Iribe G, Yamada H, Matsunaga A, Yoshimura N. Crit Care Med; 2000 Mar 31; 28(3):743-8. PubMed ID: 10752824 [Abstract] [Full Text] [Related] Page: [Next] [New Search]